Zentalis Pharmaceuticals Announces Pricing of Initial Public Offering

    NEXT STORY
    UPDATE – Prolacta Bioscience Reassures Hospitals of the Safety of Its Human Milk-Based Nutritional Products During the Coronavirus Pandemic
    PREV STORY
    Nevada Gold Mines Provides Covid-19 Support for Local Communities
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Biocartis Group NV: Biocartis and AstraZeneca Enter Into Agreement Aimed at Faster Lung Cancer Biomarker Results

    PRESS RELEASE: 29 November 2018, 07:00 CET  Biocartis and AstraZeneca Enter Into Agreement  Aimed at ...

    author_avatar
    NASDAQ Market News

    Syneos Health Launches Catalyst Ophthalmology Site Network to Support Faster Start Up and Efficient Trial Delivery

    author_avatar
    NASDAQ Market News

    Cellectar Biosciences Further Deepens Intellectual Property Portfolio with Patent Grant for PET Imaging PDC

    MADISON, Wis., March 21, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the “company”), ...

    author_avatar
    NASDAQ Market News